APOLLO HOSPITALS ENTER. L vs IND SWIFT LABORATORIES LT

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and IND SWIFT LABORATORIES LT (INDSWFTLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs INDSWFTLAB on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.32
P/E ratio
77.57
12.55
P/B ratio
1.30
0.23%
Dividend yield
0.00%
₹135.04
EPS
₹4.77

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
3.87%
18.00%
Return on capital
5.00%
15.00%
EBITDA margin
7.00%
7.94%
Net margin
6.40%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-19.02%
33.39%
Profit CAGR (3Y)
-5.12%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.26L Cr
Market cap
₹3,216 Cr
₹25,228 Cr
Revenue
₹641 Cr
₹2,003 Cr
Net profit
₹41 Cr
0.32
Debt / equity
0.01
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
IND SWIFT LABORATORIES LT
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company is expected to give good quarter"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of -6.37% over past five years.", "Company has a low return on equity of 6.11% over last 3 years.", "Earnings include an other income of Rs.44.1 Cr.", "Debtor days have increased from 89.4 to 113 days.", "Working capital days have increased from 94.1 days to 165 days"]
APOLLO HOSPITALS ENTER. L full analysis IND SWIFT LABORATORIES LT full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs INDSWFTLAB: Share Price, Valuation & Which to Buy | DocStoX